Home » Archive

Articles in the News Category

[14 Nov 2017]

Stellarray, Inc., an Austin developer of novel x-ray sources, announced today it has been awarded a contract with the U.S. Department of Energy’s National Nuclear Security Administration (NNSA) to complete development of its self-contained blood irradiator (SCBI), which will help eliminate the need for dangerous radioactive isotopes. The 18-month contract is for Phase III of the small business innovation research project the company began for NNSA in 2014 to develop this irradiator. The objective of Phase III is to finish testing the x-ray sources, deploy beta …

[14 Jun 2017]

Stellarray is pleased to announce that we have again received the City of Austin’s award for “Excellence in Pretreatment” for our water quality management program. This was the second year in a row we have received this award and the third time overall. Stellarray uses small amounts of industrial water in making our cold cathode devices and x-ray panels. We have implemented water treatment processes to ensure that nothing harmful to the environment is discharged from our facility.

[10 May 2017]

Stellarray announced today that it has been awarded the Phase 2 contract for the “Multi-Purpose X-ray Source and System” it is developing for NASA to use in crewmember imaging systems on future orbital, asteroid and planetary missions. MPXS will meet imaging needs for most of NASA’s priority “exploratory medical conditions”, including musculoskeletal, head and neck, soft tissue, dental and other conditions. MPXS will have less than 1% of the weight and volume of a traditional CT system. On earth, it will be used in portable tomosynthesis …

[20 Jan 2017]

Stellarray will present its research on a “Multi-Purpose X-ray Source and System for Exploration Medical Condition Imaging” at this year’s NASA Human Research Program Investigators’ Workshop in Galveston, TX, January 23-26. The MPXS system will be a compact radiographic medical imaging system that can be carried into space and used on future orbital, planetary and asteroid missions for traditional 2D x-ray imaging, digital tomosynthesis and other forms of 3D computed tomography. MPXS will meet imaging needs for most of NASA’s priority “exploratory medical conditions”, including musculoskeletal, head …

[16 Nov 2016]

Stellarray announced today that it is being issued U.S. Patent 9,508,523, for its “Forward Flux Channel X-ray Source” by the U.S. Patent and Trademark Office. The inventors are Mark Eaton and Dr. Mark Lucente. All rights, title and interest are assigned to Stellarray, Incorporated. The patent covers a novel x-ray source architecture in which x-rays are generated inside one or more specially shaped channels inside a metal anode plate.
There are several advantages and unique applications of this x-ray source. First, producing …

[28 Jul 2016]

Mark Eaton, Stellarray CEO, presented a paper entitled “Self-Contained Irradiators for Cesium-137 Replacement” yesterday at the Institute of Nuclear Materials Management (INMM) Annual Meeting in Atlanta. The invited paper discussed the market dynamics of Cs-37 replacement and recent progress in the development of the company’s irradiator products, including operation of the flat panel x-ray sources used in the irradiators to over 160 kilovolts, a key milestone for the company. Cs-137 is the top priority for replacement among isotopes used in medicine, research and industry due to its long …

[30 Jun 2016]

Stellarray announced today that it has begun a project for the National Aeronautics and Space Administration (NASA) to develop a radiographic medical imaging system that can be carried into space and used on future orbital, planetary and asteroid missions. The project, a six-month Phase I effort under NASA’s Small Business Innovation Research (SBIR) program, will produce designs and prove out unique hardware components for a Multi-purpose X-ray Source and System (MPXS) that can be used not only for traditional 2D x-ray imaging but also for digital tomosynthesis and …

[21 Jan 2016]

Austin, TX
Stellarray announced today that it has been issued U.S. Patent number 9,242,019, for a “UV Pipe”, by the U.S. Patent and Trademark Office.   The inventor is Mark Eaton and all rights are assigned to Stellarray, Incorporated.   In one version, this invention uses ultraviolet-emitting phosphors coated on the outside of a quartz or glass pipe to emit uniform, concentrated light to whatever is flowing inside.   The phosphors, which can be UV-C emitting phosphors for sterilization purposes, are activated by current from a cathode array disposed on the inner surface of …

[20 Jan 2016]

November 6, 2015
Stellarray is pleased to announce that the company’s “Smart X-ray Source” has won first place in the medical category in the 2015 Create the Future design contest, as judged by a panel of 60 leading scientists and engineers.  The contest was organized by NASA/Tech Briefs magazine and sponsored by COMSOL, Mouser Electronics, Analog Devices and Intel.   Over 1,100 inventions were submitted this year in six categories, with about 100 in the medical category, by government laboratories, universities, businesses and individuals from around the world.  Mark Eaton, President and …

[19 Jan 2016]

Stellarray announced today that it has been issued U.S. Patent number 9,242,019, for the “UV Pipe”, by the U.S. Patent and Trademark Office.   The inventor is Mark Eaton and all rights are assigned to Stellarray, Incorporated.   In its first embodiment, this invention uses ultraviolet-emitting phosphors coated on the outside of a quartz or glass pipe to emit uniform, concentrated light to whatever is flowing inside.   The phosphors, which can be UV-C emitting phosphors for sterilization purposes, are activated by current from a cathode array disposed on the inner surface of …